KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Long-Term Deferred Tax (2016 - 2019)

Fulgent Genetics' Long-Term Deferred Tax history spans 4 years, with the latest figure at $3.2 million for Q4 2019.

  • For Q4 2019, Long-Term Deferred Tax changed N/A year-over-year to $3.2 million; the TTM value through Dec 2019 reached $3.2 million, changed N/A, while the annual FY2019 figure was $3.2 million, N/A changed from the prior year.
  • Long-Term Deferred Tax for Q4 2019 was $3.2 million at Fulgent Genetics, up from $929000.0 in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $3.2 million in Q4 2019 and bottomed at $27000.0 in Q3 2017.
  • The 4-year median for Long-Term Deferred Tax is $106000.0 (2016), against an average of $560700.0.
  • The largest annual shift saw Long-Term Deferred Tax tumbled 68.6% in 2017 before it skyrocketed 3340.74% in 2018.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $54000.0 in 2016, then surged by 133.33% to $126000.0 in 2017, then surged by 637.3% to $929000.0 in 2018, then surged by 245.21% to $3.2 million in 2019.
  • Per Business Quant, the three most recent readings for FLGT's Long-Term Deferred Tax are $3.2 million (Q4 2019), $929000.0 (Q3 2018), and $592000.0 (Q2 2018).